Radioiodinated (—)-2-[4-(3-iodophenyl) piperidino] cyclohexanol a potential radioligand for mapping presynaptic cholinergic neurons

Nuclear Medicine Communications

Volumn 17, Issue 6, 1996, Pages 485-492

  Shiba, K ^a   Mori, H ^a   Matsuda, H ^c   Ichikawa, A ^b   Tonami, N ^b  

^a Radioisotope Centre   (United Kingdom)

^b KANAZAWA UNIVERSITY   (Japan)

^c National Center Hospital of Neurology and Psychiatry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; IODINE 125; KETANSERIN; NICOTINE; PENTAZOCINE; PRESYNAPTIC RECEPTOR; SPIPERONE; VESAMICOL; VESAMICOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NEUROTRANSMISSION; RAT;

EID: 0030003978     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199606000-00006     Document Type: Article

References (17)

1. 125I]RTI-55: A potent ligand for dopamine transporters. Eur J Pharmacol 1991; 194: 133-134.
2. 125I]iodophenyl) tropane. Mol Pharmacol 1993; 43: 264-270.
3. nC] WIN 35,428. Synapse 1993; 15: 130-142.
4. Hume SP, Pascali C, Pike VW, Turton DR, Ahier RG, Myers R et al, Citalopram: Labelling with carbon-11 and evaluation in rat as a potential radioligand for in vivo PET studies of 5-HT re-uptake sites. Nucl Med Biol 1991; 18: 339-351.
5. 125I]5- iodo-6-nitroquipazine: A potent and selective ligand for the 5-hydroxyptamine uptake complex. Brain Res 1993; 619: 236-246.
6. 11C Inisoxetine, a norepinephrine uptake inhibitor. Nucl Med Biol 1989; 16: 771-774.
7. Kilboum MR, Jung YM, Haka MS, Gildersleeve DL, Kuhl, DE et al Mouse brain distribution of a carbon-11 labeled vesamicol derivative: Presynaptic marker of cholinergic neurons. Life Sci 1990; 47: 1955-1963.
8. Widen L, Eriksson L, Ingvar M, Parsons SM, Rogers GA et al. Positron emission tomographic studies of central cholinergic nerve terminals. Neurosci Lett 1992; 136: 1-4.
9. Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann, RJ et al. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J. Nucl Med 1994; 35: 405-410.
10. McGeer PL. Aging, Alzheimer’s disease, and the cholinergic system. Can J Physiol Pharmacol 1984; 62: 741-754.
11. Reinikainen KJ, Soininen H, Riekkinen PJ. Neurotransmitter changes in Alzheimer’s disease: Implications for diagnostics. J Neurosci Res 1990; 27: 576-586.
12. Pascual J, Fontan A, Zarranz JJ, Beeciano J, Florez J, Pazos A. High-affinity choline uptake carrier in Alzheimer’s disease: Implications for the cholinergic hypothesis of dementia. Brain Res 1991; 21: 170-174.
13. 3H]-piperidino) cyclohexanol. Proc Natl Acad Sci USA 1986; 83: 2267-2270.
14. Marshall IG, Parsons SM. The vesicular acetylcholine transport system. TINS 1987; 10: 174-177.
15. Jung YW, Van Dort ME, Gildersleeve DL, Wieland DM. A radiotracer for mapping cholinergic neurons of the brain. J Med Chem 1990; 33: 2065-2068.
16. Efange SMN, Dutta AK, Michelson RH, Kung HF, Thomas JR et al. Radioiodinated 2-hydroxy-3-(4-iodophenyl)- l-(4-phenylpiperidinyl) propane: Potential radiotracer for mapping central cholinergic innervation in vivo. Nucl Med Biol 1992; 19: 337-348.
17. Shiba K, Mori H, Matsuda H, Tsuji S, Kuji S, Sumiya H et al. Synthesis of radioiodinated analogues of 2-(4-phenyl- piperidino) cyclohexanol (vesamicol) as vesamicol-like aeent. Nucl Med Biol 1995; 22: 205-210.